Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Bader-Meunier

Showing results (101-110 of 231) with videos related to

Pageof 24
Sort By:
Rheumatology (Oxford, England)|October 31, 2019
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technologyCyril Gitiaux, Vincent Bondet, Nassima Bekaddour, et al.
Seminars in Arthritis and Rheumatism|November 7, 2018
Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritisBrigitte Bader-Meunier, Roman Krzysiek, Irène Lemelle, et al.
Brain : a Journal of Neurology|October 19, 2018
A child with severe juvenile dermatomyositis treated with ruxolitinibFlorence A Aeschlimann, Marie-Louise Frémond, Darragh Duffy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 15, 2025
Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositisBenjamin Fournier, Jamie Sugrue, Anne Welfringer-Morin, et al.
Rheumatology (Oxford, England)|January 24, 2020
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technologyCyril Gitiaux, Vincent Bondet, Nassima Bekaddour, et al.
The Journal of Biological Chemistry|May 2, 2002
Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferaseIsabelle Chantret, Thierry Dupré, Christophe Delenda, et al.
Journal of Medical Genetics|November 28, 2019
Cardiac valve involvement in <i>ADAR</i>-related type I interferonopathyYanick Crow, Nandaki Keshavan, Jacques Patrick Barbet, et al.
Rheumatology (Oxford, England)|February 24, 2018
Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositisJessie Aouizerate, Marie De Antonio, Brigitte Bader-Meunier, et al.
Arthritis and Rheumatism|April 11, 2003
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typePierre Quartier, Pierre Taupin, Franck Bourdeaut, et al.
The Journal of Pediatrics|June 2, 2006
Rituximab therapy for childhood-onset systemic lupus erythematosusM Willems, E Haddad, P Niaudet, et al.
Pageof 24

Showing results (101-110 of 231) with videos related to

Sort By:
Pageof 24
Rheumatology (Oxford, England)|October 31, 2019
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technologyCyril Gitiaux, Vincent Bondet, Nassima Bekaddour, et al.
Seminars in Arthritis and Rheumatism|November 7, 2018
Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritisBrigitte Bader-Meunier, Roman Krzysiek, Irène Lemelle, et al.
Brain : a Journal of Neurology|October 19, 2018
A child with severe juvenile dermatomyositis treated with ruxolitinibFlorence A Aeschlimann, Marie-Louise Frémond, Darragh Duffy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 15, 2025
Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositisBenjamin Fournier, Jamie Sugrue, Anne Welfringer-Morin, et al.
Rheumatology (Oxford, England)|January 24, 2020
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technologyCyril Gitiaux, Vincent Bondet, Nassima Bekaddour, et al.
The Journal of Biological Chemistry|May 2, 2002
Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferaseIsabelle Chantret, Thierry Dupré, Christophe Delenda, et al.
Journal of Medical Genetics|November 28, 2019
Cardiac valve involvement in <i>ADAR</i>-related type I interferonopathyYanick Crow, Nandaki Keshavan, Jacques Patrick Barbet, et al.
Rheumatology (Oxford, England)|February 24, 2018
Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositisJessie Aouizerate, Marie De Antonio, Brigitte Bader-Meunier, et al.
Arthritis and Rheumatism|April 11, 2003
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typePierre Quartier, Pierre Taupin, Franck Bourdeaut, et al.
The Journal of Pediatrics|June 2, 2006
Rituximab therapy for childhood-onset systemic lupus erythematosusM Willems, E Haddad, P Niaudet, et al.
Pageof 24